Felbatol (Meda Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Felbatol drug offered from Meda Pharmaceuticals Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meda Pharmaceuticals Inc.
NON-PROPRIETARY NAME: felbamate
SUBSTANCE NAME: FELBAMATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-07-29
END MARKETING DATE: 0000-00-00


Felbatol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFelbatol from Meda Pharmaceuticals Inc.
LABELER NAME: Meda Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 1993-07-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-0430_1f3aad90-0bde-11e1-be50-0800200c9a66
PRODUCT NDC: 0037-0430
APPLICATION NUMBER: NDA020189

Other FELBAMATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Felbamate
Amneal Pharmaceuticals LLCFelbamate
Cadila Healthcare LimitedFelbamate
Carilion Materials ManagementFelbamate
CorePharma, LLCFelbamate
Impax GenericsFelbamate
Marlex Pharmaceuticals IncFelbamate
Meda Pharmaceuticals Inc.Felbatol
Mylan Pharmaceuticals Inc.Felbamate
Taro Pharmaceuticals U.S.A., Inc.Felbamate
Taro Pharmaceuticals U.S.A., inc.Felbamate
Wallace Pharmaceuticals Inc.Felbamate
Zydus Pharmaceuticals (USA) Inc.Felbamate